It has been a true dog of late! Directors use it as a csh machine while investors are sitting on dead money it would seem. Unless of course the shares are being held down in preparation for a low-ball bid. Maybe of held thenm too long and am beginning to hallucinate.
If I'd been making sandcastles for the length of time I've held these shares, there'd be no sand left on the beach!
IMHO I think the future (long term) prospects depend very much on any growth in sales of Varithena in the US, which is far from certain at present. Foam sclerotherapy is not an established therapy in America (yet) and it has to compete with some proven and effective modern minimally invasive techniques such as laser treatment and radiofrequency ablation. It's going to be a while yet before we know whether Varithena can gain a foothold over there.
I've come this far so I'm sticking with it, for now.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.